← Back to patent-cliff list
PTH-IA
Tier C — Watch / tradePTH-IA
Nidcr
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：PTHR
Indications (approved)：詹森氏干骺端软骨发育不良
Regional status
US
Phase II
2026-05-27
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of PTH-IA?
Approved indications include: 詹森氏干骺端软骨发育不良.
When does the PTH-IA patent expire?
No public expiry year is available for PTH-IA yet; this page updates once verified.
How do I get a quote for PTH-IA intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29